Skip to main navigation Skip to search Skip to main content

Phase I/II, randomized, observer-blind, dose-ranging (4 Log CCID50/dose; 5 Log CCID50/dose, 6 Log CCID50/dose), YF-VAX-controlled, multi-center study in 572 adults in USA

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date02/27/20 → 02/26/21

Funding

  • Sanofi Pasteur Incorporated: $62,800.00